Loeb Says Amgen Has Multiple Personalities, Should Be Broken Up; Company 'Appreciates' Input

Daniel Loeb’s hedge fund, Third Point LLC, might think its latest investment, Amgen, Inc. (NASDAQ:AMGN), has a multiple investment personality disorder. Loeb divides Amgen into two distinct companies In a letter to investors Loeb recommended the company be divided into two distinct companies: one a fast growing growth company, well suited for the active, momentum traders; and a second company, the mature growth company, that delivered solid dividends to shareholders. The Third Point letter even nicked named the companies GrowthCo and MatureCo, each appealing to a different investor segment.  In creating these two investment products, the hedge fund manager of…